Hypertrophic cardiomyopathy (HCM) is a disease involving the cardiac sarcomere. It is
associated with various disease-causing gene mutations and phenotypic expressions …

Background: Left ventricular outflow tract obstruction complicates hypertrophic
cardiomyopathy and transcatheter mitral valve replacement. Septal reduction therapies …

Hypertrophic cardiomyopathy is an important cause of heart failure and arrhythmias,
including sudden death, with a major impact on the healthcare system. Genetic causes and …

Severe left ventricular outflow tract obstruction (LVOTO) of hypertrophic cardiomyopathy is
an acutely life-threatening, must-not miss, cardiology emergency that infrequently presents …

Hypertrophic obstructive cardiomyopathy is a hereditary condition that affects myocardial
contraction. In case of failure of pharmacological treatment, alternative approaches might be …

Obstructive hypertrophic cardiomyopathy (oHCM) is an inherited myocardial disease,
caused by mutations in genes encoding sarcomere (or sarcomere-related structures) …

The evolution of therapeutic options in the treatment of Hypertrophic Obstructive
Cardiomyopathy (HOCM) was characterized by several milestones since its first description …

Transcatheter myotomy is a novel approach to address LVOT obstruction related to
hypertrophic cardiomyopathy in patients who are not favorable surgical candidates. The risk …

Background Radiofrequency catheter ablation (RFCA) has emerged as a therapeutic option
for surgical myectomy and alcohol septal ablation (ASA) in patients with hypertrophic …

Background: Right ventricular involvement in hypertrophic cardiomyopathy is uncommon.
This study aimed to evaluate clinical outcomes of the modified septal myectomy in patients …